NEWS RELEASE
Manufacturing Company Resumes Operations in Delaware
Advanced Aerosol Acquisition Awarded Funding from the State
DOVER, Del. (Oct.1, 2009) - The Delaware Economic Development Office awarded Analytical
Biological Services, Inc., a bioscience company located in Wilmington, a Delaware Strategic Fund
grant in the amount of $50,000. The grant will provide funding for a ground-breaking drug discovery
technology being developed by ABS and an international team of collaborators.
The failure of drugs to reach their targets or in the case of some anti-cancer agents to be pumped out of
tumors is a multi-billion dollar problem for pharmaceutical companies and healthcare practitioners.
ABS' BiosomesR technology is aimed at providing a cost-effective solution to this problem.
"Fostering research and development at companies like Analytical Biological Services creates jobs and
moves our economy forward," said Governor Jack Markell.
ABS was previously awarded $89,271 for Phase I of the Small Business Innovation Research Grant
from the National Institutes of Health for their technology, which combines computer modeling and
simple lab tests to predict whether or not potential drugs can effectively reach their targets in the
human body, such as cancer tumors. Upon the successful completion of Phase I, ABS applied for
nearly $1.7 million in Phase II SBIR funding from NIH. The grant from DEDO will enable the
continuation of this project between these two SBIR Phases, and will lead to the creation of new high
paying bioscience jobs in Delaware.
"The investment in ABS supports our efforts to encourage entrepreneurial business growth," said Alan
Levin, director of DEDO. "The kind of research performed by technology-based companies like ABS
will bring innovative new products, jobs and revenue to the state."
"The grant program from the state of Delaware is critical to helping us continue our research," said Dr.
Charles Saller, president and chief executive officer of ABS. "I would particularly like to thank
Director Alan Levin and Patricia Cannon of DEDO for their help in making this grant possible."
Phase II of the project will immediately create three new Delaware jobs, with the potential to create up
to 20 additional jobs upon completion of the project. The company currently employs eight high-wage
scientists and researchers.
About the Delaware Economic Development Office
The Delaware Economic Development Office is an executive state of Delaware agency responsible for attracting new investors and businesses to the state, promoting the expansion of existing industry, assisting small and minority-owned businesses, promoting and developing tourism and creating new and improved employment opportunities for all citizens of the State. DEDO is a Certified Economic Development Organization, accredited by the International Economic Development Council. Visit dedo.delaware.gov.
About Analytical Biological Services, Inc.
ABS is small bioscience company located in Wilmington, Del. It was founded in January 1990 by Dr.
Charles Saller, president and chief executive officer. Since then, ABS has grown to serve nearly every
major pharmaceutical company in the world, providing custom biological products and services for
drug discovery and medical diagnostics. ABS has also maintained an in-house research program that is
aimed at providing drug discovery and diagnostics technologies for researchers and medical
professionals. Visit www.absbio.com.
Contact:
Nikki Boone, Communications Manager
Delaware Economic Development Office
nikki.boone@state.de.us
302-672-6857
Charles Saller, Ph.D., President & CEO
Analytical Biological Services, Inc.
csaller@absbio.com
302-654-4492 x217
